Shots :
Following the approval from the Drug Controller General of India (DCGI), Glenmark has introduced the first biosimilar of Liraglutide under the brand name Lirafit (1.2mg, per day) for managing type 2 diabetes mellitus in India
Lirafit gained approval based on a 24wks. study in type 2 diabetes mellitus Indian adult patients which showed…
